David Donabedian is the founder of ImmuneID. ImmuneID has raised $113M in total funding. Latest round: Series A. Based in Cambridge, Massachusetts, US.
David Donabedian is the founder of ImmuneID, a precision immunology company based in Cambridge, Massachusetts that develops therapeutics targeting antibody interactions driving immune diseases. He has raised over $113 million in equity funding across Series A and B rounds from various investors.
Full founder directory · Investor directory · Company funding database · Fundraising library